Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral useInitial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
STRIBILD® is indicated as a complete regimen for the treatment of HIV-1 infection in adults who are antiretroviral treatment-naïve.
- generic_name
- elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
- product_names
- elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
- ndc
- 53808-0887, 61958-1201, 53808-0887-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en